S'pore company at centre of Brazil's probe into import of Indian vaccine

A unit on level one of the shophouse at 31 Cantonment Road was occupied by Sashi & Sekar Associates on July 13, 2021. ST PHOTO: JOYCE LIM
New: Gift this subscriber-only story to your friends and family

SINGAPORE/BANGALORE - A Singapore-based company is at the centre of a Brazil government probe into alleged irregularities over the South American country's deal to purchase India's indigenous Covid-19 vaccine Covaxin.

With the world's highest death toll from Covid-19 after the United States, Brazil desperately needs vaccines, but on June 29, it cancelled its US$320 million (S$433 million) February contract with Indian vaccine maker Bharat Biotech over allegations of corruption in the deal. The company was to supply 20 million doses of Covaxin, developed with Indian government support.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.